| 영문 | rheumatoid factor | 한글 | 류마티스 인자 |
|---|---|---|---|
| 설명 | IgG의 Fc부위에 있는 항원결정인자에 대한 항체로서 전형적인 또는 확실한 류마티스관절염(rheumatoid arthritis) 환자의 80%에서 발견된다. 류마티스 인자는 IgM, IgG, IgA중 하나가 될 수 있으나 주로 IgM이다. 소아류마티스관절염(juvenile rheumatoid arthritis: 소아기에 발생하는 류마티스관절염)을 비롯한, 다른 결합조직병이나 감염병에도 나타날 수 있다 |
||
| 영문 | growth factor | 한글 | 성장인자 |
|---|---|---|---|
| 설명 | 세포의 분화 및 성장에 관여하는 단백질. 성장인자는 정상 세포주기에 필수적이기 때문에 동물의 생명에 중대한 요소가 된다. 무엇보다도 성장인자는 태아의 발육을 조정하고 조직의 유지 및 보수에 중대한 역할을 하며, 혈구의 생성을 자극한다. 또한 암의 진행과정에도 관여한다. |
||
| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10－3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10－3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10－3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10－3/Sv이다. |
||
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
|---|---|
| EF | ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e... |
| PF | pair feeding; peak flow; perfusion fluid; pericardial fluid; periosteal fibroblast; peritoneal fluid... |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| SF | Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f... |
| EDRF | endothelium derived relaxation factor |
|---|---|
| EDR | Endothelium-dependent relaxation |
| HRT | Half-relaxation time |
| IRP | Isovolumic relaxation period |
| IRT | Isovolumic relaxation time |
IGF-II : insulin like growth factor-II의 약자. 많은 장기와 조직에 작용하여 단백 합성과 DNA, RNA의 합성을 증가시켜 세포의 수와 양을 증가
| relaxation factor | Substance presumably involved in the return of muscle fibrils to the resting state after nervous stimulation ceases, postulated to act by withdrawing Calcium from myosin-ATPase sites. (05 Mar 2000) |
|---|
| endothelium derived relaxation factor | <biochemistry> This compound is produced from L arginine by the enzyme nitric oxide synthase. Acts as a potent vasorelaxant via elevation of intracellular cGMP in vascular smooth muscle. Synthesis of nitric oxide is not confined to endothelium, isoforms of nitric oxide synthase are also found in brain, neutrophils and platelets. Synonym: endothelium derived relaxation factor. Acronym: NO (29 Dec 1997) |
|---|---|
| cardioesophageal relaxation | Relaxation of the lower oesophageal sphincter which can allow reflux of acidic gastric contents into the lower oesophagus, producing oesophagitis. (05 Mar 2000) |
| relaxation | A state of relative freedom from both anxiety and skeletal muscle tension. (16 Dec 1997) |
| relaxation response | An integrated hypothalamic reaction resulting in decreased sympathetic nervous system activity which, physiologically and psychologically, is almost a mirror image of the body's response's to Cannon's emergency theory (flight or fight response); can be self-induced through the use of techniques associated with transcendental meditation, yoga, and biofeedback. See: emergency theory. (05 Mar 2000) |
| relaxation suture | A suture so arranged that it may be loosened if the tension of the wound becomes excessive. (05 Mar 2000) |
| relaxation techniques | The use of muscular relaxation techniques in treatment. (12 Dec 1998) |
| relaxation time | Time taken for a system to return to the resting or ground state or a new equilibrium state following perturbation. Often used in context of receptor systems that have a refractory period after responding and then relax to a competent state. Can be used more precisely to mean the time for a system to change from its original equilibrium value to 1/e of this original value. (18 Nov 1997) |
| muscle relaxation | That phase of a muscle twitch during which a muscle returns to a resting position. (12 Dec 1998) |
| progressive muscle relaxation | A cognitive-behavioural strategy in which muscles are alternately tensed and then relaxed in a systematic fashion. (16 Dec 1997) |
| spin-lattice relaxation | In nuclear magnetic resonance, the return of the magnetic dipoles of the hydrogen nuclei (magnetization vector) to equilibrium parallel to the magnetic field, after they have been flipped 90 |
| spin-spin relaxation | In nuclear magnetic resonance, the return of the magnetic dipoles of the hydrogen nuclei (magnetization vector) to equilibrium parallel to the magnetic field, after they have been flipped 90 |
| isometric relaxation | Decrease in tension of a muscle while the length remains constant due to fixation of the ends. (05 Mar 2000) |
| isometric relaxation period | Early ventricular diastole beginning with closure of the aortic and pulmonic valves and preceding opening of the atrioventricular valves. (05 Mar 2000) |
| isovolumetric relaxation | That part of the cardiac cycle between the time of aortic valve closure and mitral opening, during which the ventricular muscle decreases its tension without lengthening so that ventricular volume remains unaltered; the heart is never precisely isovolumetric (vs. Isovolumic) except during long diastoles with a midiastolic period of diastasis. Synonym: isovolumetric relaxation. (05 Mar 2000) |
| isovolumic relaxation | That part of the cardiac cycle between the time of aortic valve closure and mitral opening, during which the ventricular muscle decreases its tension without lengthening so that ventricular volume remains unaltered; the heart is never precisely isovolumetric (vs. Isovolumic) except during long diastoles with a midiastolic period of diastasis. Synonym: isovolumetric relaxation. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|